A nurse is reinforcing teaching to a client who is to undergo transcranial magnetic stimulation (TMS) for depression. Which of the following information should the nurse provide?

A. Fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat depression, anxiety, and obsessive-compulsive disorder. It does not alleviate tardive dyskinesia symptoms and is not indicated for managing extrapyramidal side effects.
B. Diphenhydramine. Diphenhydramine is an antihistamine that can help with acute dystonic reactions due to its anticholinergic effects, but it does not treat tardive dyskinesia. Long-term use may even worsen movement disorders.
C. Naloxone. Naloxone is an opioid antagonist used to reverse opioid overdose. It has no effect on tardive dyskinesia, as this condition is related to prolonged dopamine receptor blockade rather than opioid activity.
D. Valbenazine. Valbenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor specifically approved for the treatment of tardive dyskinesia. It helps regulate dopamine release and reduces involuntary movements associated with the condition.

A. "Persistent depressive disorder is a mild chronic form of depression." PDD, previously known as dysthymia, is a long-lasting depressive condition with persistent low mood for at least two years. Symptoms are less severe than major depressive disorder but are continuous and can significantly impact daily life. While not as acute as major depression, PDD requires management through therapy, medication, and lifestyle modifications.
B. "Persistent depressive disorder is characterized by delusions and hallucinations." Psychotic features such as delusions and hallucinations are not typical of persistent depressive disorder (PDD). These symptoms are more commonly associated with major depressive disorder with psychotic features or schizophrenia. PDD primarily involves chronic low-grade depression rather than severe psychotic symptoms.
C. "Persistent depressive occurs shortly after taking or withdrawing from a substance." Substance-induced depressive disorder is a distinct diagnosis that results from drug use or withdrawal. Persistent depressive disorder is not caused by substance use but is a long-term mood disorder that lasts for at least two years. The symptoms are chronic and not directly linked to substance intake or withdrawal.
D. "Persistent depressive is characterized by both manic and depressive episodes." Bipolar disorder, not persistent depressive disorder, is characterized by alternating manic and depressive episodes. PDD involves a chronic, low-level depressive state without manic symptoms. Individuals with PDD may experience periods of worsening depression, but they do not exhibit the high-energy or euphoric states seen in bipolar disorder.